INIS
screening
100%
diseases
100%
lungs
100%
liver
100%
cancer
100%
assessments
100%
mortality
31%
risks
25%
fats
25%
hazards
18%
computed tomography
12%
chest
12%
values
6%
females
6%
comparative evaluations
6%
units
6%
learning
6%
death
6%
range
6%
Keyphrases
Lung Cancer Screening
100%
Steatotic Liver Disease
100%
Hepatic Fat Fraction
44%
Risk Factors
22%
Chest CT
22%
Hazard Ratio
22%
All-cause Mortality
22%
Heavy Smokers
22%
Liver
22%
National Lung Screening Trial
22%
Confidence Interval
11%
Increased Mortality
11%
End-stage Liver Disease
11%
Long-term Mortality
11%
Liver-related Mortality
11%
Prognostic Value
11%
Noncontrast-enhanced
11%
1-year Follow-up
11%
Hounsfield Units
11%
Clinical Risk Factors
11%
Trial Participants
11%
Worse Outcome
11%
Lean Mass Index
11%
Deep Learning Model
11%
Lung Screening
11%
Cox Proportional Hazards Regression
11%
Immunology and Microbiology
Computer Assisted Tomography
100%
Cancer Screening
100%
Body Mass
50%
Lean Body Weight
50%
All Cause Mortality
50%
Medicine and Dentistry
Liver Disease
100%
Lung Cancer Screening
100%
Computer Assisted Tomography
22%
Hazard Ratio
22%
National Lung Screening Trial
22%
Malignant Neoplasm
11%
Body Mass Index
11%
Proportional Hazards Model
11%
Lean Body Weight
11%
All Cause Mortality
11%
End Stage Liver Disease
11%
Lung
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Liver Disease
100%
Malignant Neoplasm
11%
All Cause Mortality
11%
End Stage Liver Disease
11%